Advantage and Value Plus formulary update
2nd and 3rd quarter 2020
The Capital Blue Cross formulary is a reference list of prescription drugs that contains a wide range of generic and brand drugs that have been approved by the U.S. Food and Drug Administration (FDA). The formulary is updated on a quarterly basis or when new generic or brand-name medications become available and as discontinued drugs are removed from the marketplace.
Several new drugs have come to market and are now included in our formulary.
Pharmacy Management Program update
Key:
(PAR) = Prior Authorization Required
(EPA) = Enhanced Prior Authorization Required
(QLL) = Quantity Level Limits Apply — Quantity Level Limit (QLL) Program
(BP) = Brand Preferred
(BNP) = Brand Non-Preferred
(NC) = Not Covered
(NF) = Non-Formulary
UPPERCASE names = Brand
lowercase names = Generic
1Indicates Specialty Medication
Impacted members will be notified prior to change. Drugs that are listed in the target drug box include both brand and generic unless otherwise stated; dosage forms are not all encompassing and is subject to change.
The information contained on this page is not all encompassing and is subject to change. Please refer to your Certificate of Coverage for specific terms, conditions, exclusions and limitations relating to your coverage.